Cargando…

Institutional case volume and mortality after aortic and mitral valve replacement: a nationwide study in two Korean cohorts

BACKGROUND: There are only a handful of published studies regarding the volume-outcome relationship in heart valve surgery. We evaluated the association between institutional case volume and mortality after aortic valve replacement (AVR) and mitral valve replacement (MVR). METHODS: Two separate coho...

Descripción completa

Detalles Bibliográficos
Autores principales: Nam, Karam, Jang, Eun Jin, Jo, Jun Woo, You, Jiwon, Park, Jung-Bin, Ryu, Ho Geol
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9392916/
https://www.ncbi.nlm.nih.gov/pubmed/35987643
http://dx.doi.org/10.1186/s13019-022-01945-0
_version_ 1784771160196513792
author Nam, Karam
Jang, Eun Jin
Jo, Jun Woo
You, Jiwon
Park, Jung-Bin
Ryu, Ho Geol
author_facet Nam, Karam
Jang, Eun Jin
Jo, Jun Woo
You, Jiwon
Park, Jung-Bin
Ryu, Ho Geol
author_sort Nam, Karam
collection PubMed
description BACKGROUND: There are only a handful of published studies regarding the volume-outcome relationship in heart valve surgery. We evaluated the association between institutional case volume and mortality after aortic valve replacement (AVR) and mitral valve replacement (MVR). METHODS: Two separate cohorts of all adults who underwent AVR or MVR, respectively, between 2009 and 2016 were analyzed using a Korean healthcare insurance database. Hospitals performing AVRs were divided into three groups according to the average annual case volume: the low- (< 20 cases/year), medium- (20–70 cases/year), and high-volume centers (> 70 cases/year). Hospitals performing MVRs were also grouped as the low- (< 15 cases/year), medium- (15–40 cases/year), or high-volume centers (> 40 cases/year). In-hospital mortality after AVR or MVR were compared among the groups. RESULTS: In total, 7875 AVR and 5084 MVR cases were analyzed. In-hospital mortality after AVR was 8.3% (192/2318), 4.0% (84/2102), and 2.6% (90/3455) in the low-, medium-, and high-volume centers, respectively. The adjusted risk was higher in the low- (OR 2.31, 95% CI 1.73–3.09) and medium-volume centers (OR 1.53, 95% CI 1.09–2.15) compared to the high-volume centers. In-hospital mortality after MVR was 9.3% (155/1663), 6.3% (94/1501), and 2.9% (56/1920) in the low-, medium-, and high-volume centers, respectively. Compared to the high-volume centers, the medium- (OR 1.97, 95% CI 1.35–2.88) and low-volume centers (OR 2.29, 95% CI 1.60–3.27) showed higher adjusted risk of in-hospital mortality. CONCLUSIONS: Lower case volume is associated with increased in-hospital mortality after AVR and MVR. The results warrant a comprehensive discussion regarding regionalization/centralization of cardiac valve replacements to optimize patient outcomes. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13019-022-01945-0.
format Online
Article
Text
id pubmed-9392916
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-93929162022-08-22 Institutional case volume and mortality after aortic and mitral valve replacement: a nationwide study in two Korean cohorts Nam, Karam Jang, Eun Jin Jo, Jun Woo You, Jiwon Park, Jung-Bin Ryu, Ho Geol J Cardiothorac Surg Research Article BACKGROUND: There are only a handful of published studies regarding the volume-outcome relationship in heart valve surgery. We evaluated the association between institutional case volume and mortality after aortic valve replacement (AVR) and mitral valve replacement (MVR). METHODS: Two separate cohorts of all adults who underwent AVR or MVR, respectively, between 2009 and 2016 were analyzed using a Korean healthcare insurance database. Hospitals performing AVRs were divided into three groups according to the average annual case volume: the low- (< 20 cases/year), medium- (20–70 cases/year), and high-volume centers (> 70 cases/year). Hospitals performing MVRs were also grouped as the low- (< 15 cases/year), medium- (15–40 cases/year), or high-volume centers (> 40 cases/year). In-hospital mortality after AVR or MVR were compared among the groups. RESULTS: In total, 7875 AVR and 5084 MVR cases were analyzed. In-hospital mortality after AVR was 8.3% (192/2318), 4.0% (84/2102), and 2.6% (90/3455) in the low-, medium-, and high-volume centers, respectively. The adjusted risk was higher in the low- (OR 2.31, 95% CI 1.73–3.09) and medium-volume centers (OR 1.53, 95% CI 1.09–2.15) compared to the high-volume centers. In-hospital mortality after MVR was 9.3% (155/1663), 6.3% (94/1501), and 2.9% (56/1920) in the low-, medium-, and high-volume centers, respectively. Compared to the high-volume centers, the medium- (OR 1.97, 95% CI 1.35–2.88) and low-volume centers (OR 2.29, 95% CI 1.60–3.27) showed higher adjusted risk of in-hospital mortality. CONCLUSIONS: Lower case volume is associated with increased in-hospital mortality after AVR and MVR. The results warrant a comprehensive discussion regarding regionalization/centralization of cardiac valve replacements to optimize patient outcomes. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13019-022-01945-0. BioMed Central 2022-08-20 /pmc/articles/PMC9392916/ /pubmed/35987643 http://dx.doi.org/10.1186/s13019-022-01945-0 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Nam, Karam
Jang, Eun Jin
Jo, Jun Woo
You, Jiwon
Park, Jung-Bin
Ryu, Ho Geol
Institutional case volume and mortality after aortic and mitral valve replacement: a nationwide study in two Korean cohorts
title Institutional case volume and mortality after aortic and mitral valve replacement: a nationwide study in two Korean cohorts
title_full Institutional case volume and mortality after aortic and mitral valve replacement: a nationwide study in two Korean cohorts
title_fullStr Institutional case volume and mortality after aortic and mitral valve replacement: a nationwide study in two Korean cohorts
title_full_unstemmed Institutional case volume and mortality after aortic and mitral valve replacement: a nationwide study in two Korean cohorts
title_short Institutional case volume and mortality after aortic and mitral valve replacement: a nationwide study in two Korean cohorts
title_sort institutional case volume and mortality after aortic and mitral valve replacement: a nationwide study in two korean cohorts
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9392916/
https://www.ncbi.nlm.nih.gov/pubmed/35987643
http://dx.doi.org/10.1186/s13019-022-01945-0
work_keys_str_mv AT namkaram institutionalcasevolumeandmortalityafteraorticandmitralvalvereplacementanationwidestudyintwokoreancohorts
AT jangeunjin institutionalcasevolumeandmortalityafteraorticandmitralvalvereplacementanationwidestudyintwokoreancohorts
AT jojunwoo institutionalcasevolumeandmortalityafteraorticandmitralvalvereplacementanationwidestudyintwokoreancohorts
AT youjiwon institutionalcasevolumeandmortalityafteraorticandmitralvalvereplacementanationwidestudyintwokoreancohorts
AT parkjungbin institutionalcasevolumeandmortalityafteraorticandmitralvalvereplacementanationwidestudyintwokoreancohorts
AT ryuhogeol institutionalcasevolumeandmortalityafteraorticandmitralvalvereplacementanationwidestudyintwokoreancohorts